ARWR
Arrowhead Pharmaceuticals : Piper Sandler Cuts Target Price to $45 From $62
时间：2024-11-27 15:40:16 市场： 美股 综合
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
时间：2024-11-27 05:00:00 市场： 综合 美股
Arrowhead Pharmaceuticals Shares Jump 25.1% After Co Announces Global License With Sarepta Therapeutics for Multiple Clinical & Preclinical Programs
时间：2024-11-26 22:32:56 市场： 美股 综合
Arrowhead Pharmaceuticals Shares Jump 28% Premarket After Co Announces Global License With Sarepta Therapeutics for Multiple Clinical & Preclinical Programs
时间：2024-11-26 21:41:03 市场： 美股 综合
Arrowhead Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
时间：2024-10-15 04:30:42 市场： 美股 综合
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of Aro-Inhbe for the Treatment of Obesity
时间：2024-09-23 19:30:00 市场： 美股 综合